Home Search
infectious diseases - search results
If you're not happy with the results, please do another search
Preventing chronic diseases through lifestyle
Chronic diseases account for the vast majority of deaths in European countries. Cardiovascular disease accounts for about 40% of deaths, with about 15% of deaths from ischaemic heart disease, 10% from strokes, and 25% from cancer. If simple lifestyle changes could reduce the risk of chronic disease, people could...
Potential cancer vaccine shows promise in animal trials
Investigators from the National Institute of Allergy and Infectious Diseases (NIAID) have announced an experimental therapeutic cancer vaccine.
Lessons from the mouse model of cutaneous leishmaniasis
Peter Bretscher, from the University of Saskatchewan looks at whether mouse models of cutaneous leishmaniasis are pertinent for vaccination against and treatment of AIDS, infectious diseases, and cancer.
Clinical trials begin for three mRNA HIV vaccines
The National Institute of Allergy and Infectious Diseases (NIAID) has launched Phase 1 clinical trials for three mRNA HIV vaccines.
Scientists say fully vaccinated people can transmit Delta variant
A UK study, published in The Lancet Infectious Diseases, found that fully vaccinated people can still catch and transmit the Delta variant of COVID.
Luke S. P. Moore – Healthcare Infection Society
Luke Moore is an Infectious Diseases Physician and Clinical Microbiologist in London with special interests in critical care infections, antimicrobial resistance, and healthcare systems.
Optimising infection control post-pandemic
Luke S. P. Moore, Infectious Diseases Physician and Clinical Microbiologist on behalf of the Healthcare Infection Society, directs our thoughts to optimising our control of infections and looks forward to the post-pandemic period.
Antimicrobial resistance (AMR): A global health concern
SACIDS Africa Centre of Excellence for Infectious Diseases trains young African scientists in research on global health issues: An example of a PhD Student Research on antimicrobial resistance (AMR).
Research finds hydroxychloroquine does not work against COVID-19
A study published in Clinical Infectious Diseases found that hydroxychloroquine did not work to protect healthcare professionals from COVID-19.
Multi-step regulation of hepatitis B virus entry
Koichi Watashi, Senior Researcher from the National Institute of Infectious Diseases, Japan, explores the trick for cell invasion in reaching regulation of hepatitis B entry.
NIAID reveals strategic plan for universal influenza vaccine
Researchers at the National Institute of Allergy and Infectious Diseases have orchestrated a plan to create a universal influenza vaccine.
A blood test breakthrough could help identify hidden tuberculosis cases
Scientists from the University of Southampton are on the verge of unveiling a blood test that could uncover millions of undetected tuberculosis (TB) cases.
Meteorological data for public health surveillance
Michael Wimberly, Professor from the University of Oklahoma, walks us through integrating meteorological data for public health surveillance and disease forecasting.
Hypervaccination: What would 217 COVID-19 vaccines do to your immune system?
Researchers looked into the case of a man who received over 200 vaccinations against Covid-19 to help deepen the understanding of hypervaccination.
Vaccine non-responders and severe adverse events
Eyer Klaus, an Associate Professor at Aarhus University’s Department of Biomedicine, explores the causes, impact, and potential resolutions of vaccine non-responsiveness and severe side effects.
How do we tackle sepsis?
How do we tackle sepsis? What role do infection prevention and control play? What are the symptoms? How do we treat sepsis and reduce its risk? Let’s discover more about sepsis here.
Data and specimen-sharing tools offer new discovery opportunities for ME/CFS researchers
Within the field of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) research, two online tools: mapMECFS (Mathur and Carnes, 2021) and searchMECFS play a crucial role in advancing the understanding of ME/CFS by encouraging researchers to share and use data and biospecimens that are stored in centralized and easily accessible data portals.
Understanding and supporting neurological conditions among the incarcerated
Samuel Han and Audrey Nath discuss neurological conditions among the incarcerated, who they argue are a medically underserved population.
The FDA approve Omalizumab for managing food allergies
The Food and Drug Administration (FDA) has an approach for the expanded use of Omalizumab (Xolair), to address allergic reactions, including anaphylaxis, stemming from accidental exposure to various foods.
Peter Timms – University Sunshine Coast
Professor Timms is Professor of Microbiology at the University of Sunshine Coast in Queensland, Australia
He is a nationally and internationally renowned microbiologist with specific expertise in the area of Chlamydia. His laboratory is acknowledged as the leading Australian laboratory and one of the leading groups internationally working on all...